Bileaflet MVP Syndrome

Bileaflet MVP Syndrome Guest: Michael J. Ackerman, M.D., Ph.D. (@MJAckermanMDPhD) Host: Paul A. Friedman, M.D. (@drpaulfriedman) Mayo Clinic researchers looked at a 10-year experience of 1,200 patients who came to the Windland Smith Rice Genetic Heart Rhythm Clinic. The researchers found that 24 of those patients were survivors of out-of-hospital cardiac arrest. Ten of those 24 survivors — 42% — had bileaflet prolapse. That finding helped the research team identify the features of arrhythmogenic bileaflet mitral valve prolapse syndrome. Joining us today to discuss arrhythmogenic bileaflet mitral valve prolapse syndrome is Michael J. Ackerman, M.D., Ph.D., a pediatric cardiologist and principal investigator at the Windland Smith Rice Sudden Death Genomics Laboratory at Mayo Clinic in Rochester, Minnesota. Specific topics discussed: Mitral valve prolapse versus arrhythmogenic bileaflet mitral valve prolapse syndrome Signs and symptoms of arrhythmogenic bileaflet mitral valve prolapse syndrome Characteristic findings of complex ectopy Work-up and next steps A role for MRI Mitral annular disjunction Treatment options A role for ablation A genetic condition or not? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV. No CME credit offered for this episode. Podcast episode transcript found here.